A look at 18 recent AI-bio Series B rounds: the bar moves higher, the diligence runs deeper, and the generalist boards that wrote the seed checks suddenly want to talk about wet-lab unit economics.
The funds making it work are the ones that staffed up with PhDs in 2023 and 2024.
